Ameriprise Financial Inc Aurinia Pharmaceuticals Inc. Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 10,815 shares of AUPH stock, worth $90,088. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,815
Previous 10,685 1.22%
Holding current value
$90,088
Previous $61,000 29.51%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$5.32 - $7.33 $691 - $952
130 Added 1.22%
10,815 $79,000
Q2 2024

Aug 14, 2024
BUY
$4.81 - $5.78 $51,394 - $61,759
10,685 New
10,685 $61,000
Q1 2020

May 15, 2020
SELL
$11.34 - $21.46 $1.67 Million - $3.15 Million
-146,841 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$3.88 - $21.42 $823,530 - $4.55 Million
-212,250 Reduced 59.11%
146,841 $2.98 Million
Q3 2019

Nov 14, 2019
SELL
$5.34 - $6.59 $17,344 - $21,404
-3,248 Reduced 0.9%
359,091 $1.92 Million
Q2 2019

Aug 14, 2019
SELL
$6.05 - $6.75 $19,184 - $21,404
-3,171 Reduced 0.87%
362,339 $2.38 Million
Q1 2019

May 15, 2019
SELL
$6.06 - $7.64 $10,277 - $12,957
-1,696 Reduced 0.46%
365,510 $2.38 Million
Q4 2018

Feb 14, 2019
SELL
$5.08 - $6.83 $10,901 - $14,657
-2,146 Reduced 0.58%
367,206 $2.5 Million
Q3 2018

Nov 14, 2018
BUY
$5.27 - $6.64 $365,527 - $460,550
69,360 Added 23.12%
369,352 $2.45 Million
Q2 2018

Aug 14, 2018
BUY
$5.06 - $6.36 $203,098 - $255,277
40,138 Added 15.45%
299,992 $1.69 Million
Q1 2018

May 15, 2018
BUY
$4.85 - $5.99 $109,129 - $134,780
22,501 Added 9.48%
259,854 $1.35 Million
Q4 2017

Feb 12, 2018
BUY
$4.53 - $7.09 $116,801 - $182,808
25,784 Added 12.19%
237,353 $1.08 Million
Q3 2017

Nov 07, 2017
BUY
$5.71 - $6.9 $1.21 Million - $1.46 Million
211,569
211,569 $1.33 Million

Others Institutions Holding AUPH

# of Institutions
207
Shares Held
58.3M
Call Options Held
914K
Put Options Held
1.35M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.18B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email